178 related articles for article (PubMed ID: 36474126)
81. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes.
Murphy WJ; Funakoshi S; Beckwith M; Rushing SE; Conley DK; Armitage RJ; Fanslow WC; Rager HC; Taub DD; Ruscetti FW
Blood; 1995 Sep; 86(5):1946-53. PubMed ID: 7544649
[TBL] [Abstract][Full Text] [Related]
82. Epstein-Barr virus (EBV)-associated lymphoproliferations in severe combined immunodeficient mice transplanted with Hodgkin's disease lymph nodes: implications of EBV-positive bystander B lymphocytes rather than EBV-infected Reed-Sternberg cells.
Meggetto F; Muller C; Henry S; Selves J; Mariamé B; Brousset P; Saati TA; Delsol G
Blood; 1996 Mar; 87(6):2435-42. PubMed ID: 8630408
[TBL] [Abstract][Full Text] [Related]
83. The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups.
Cho EY; Kim KH; Kim WS; Yoo KH; Koo HH; Ko YH
J Korean Med Sci; 2008 Apr; 23(2):185-92. PubMed ID: 18436998
[TBL] [Abstract][Full Text] [Related]
84. Compound Heterozygous DOCK8 Mutations in a Patient with B Lymphoblastic Leukemia and EBV-Associated Diffuse Large B Cell Lymphoma.
Buchbinder D; Kirov I; Danielson J; Shah NN; Freeman AF; Chavan RS; Su HC
J Clin Immunol; 2019 Aug; 39(6):592-595. PubMed ID: 31267431
[TBL] [Abstract][Full Text] [Related]
85. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features.
Richter J; John K; Staiger AM; Rosenwald A; Kurz K; Michgehl U; Ott G; Franzenburg S; Kohler C; Finger J; Oschlies I; Paul U; Siebert R; Spang R; Burkhardt B; Klapper W
Br J Haematol; 2022 Feb; 196(3):681-689. PubMed ID: 34617271
[TBL] [Abstract][Full Text] [Related]
86. Epstein-Barr virus-positive diffuse large B-cell lymphoma features disrupted antigen capture/presentation and hijacked T-cell suppression.
Jiang XN; Yu BH; Yan WH; Lee J; Zhou XY; Li XQ
Oncoimmunology; 2020; 9(1):1683346. PubMed ID: 32002294
[No Abstract] [Full Text] [Related]
87. Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy.
Lammoglia Cobo MF; Welters C; Rosenberger L; Leisegang M; Dietze K; Pircher C; Penter L; Gary R; Bullinger L; Takvorian A; Moosmann A; Dornmair K; Blankenstein T; Kammertöns T; Gerbitz A; Hansmann L
Cytotherapy; 2022 Aug; 24(8):818-826. PubMed ID: 35525797
[TBL] [Abstract][Full Text] [Related]
88. Assessment of Epstein-Barr virus association with pediatric non-hodgkin lymphoma in immunocompetent and in immunocompromised patients in Argentina.
Chabay PA; De Matteo EN; Aversa L; Maglio S; Grinstein S; Preciado MV
Arch Pathol Lab Med; 2002 Mar; 126(3):331-5. PubMed ID: 11860309
[TBL] [Abstract][Full Text] [Related]
89. Epstein-Barr virus associated with high-grade B-cell lymphoma in nude severe combined immunodeficiency.
Albar R; Mahdi M; Alkeraithe F; Almufarriji KN
BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31151968
[TBL] [Abstract][Full Text] [Related]
90. Cbl enforces an SLP76-dependent signaling pathway for T cell differentiation.
Chiang YJ; Jordan MS; Horai R; Schwartzberg PL; Koretzky GA; Hodes RJ
J Biol Chem; 2009 Feb; 284(7):4429-38. PubMed ID: 19074136
[TBL] [Abstract][Full Text] [Related]
91. An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.
Ma SD; Yu X; Mertz JE; Gumperz JE; Reinheim E; Zhou Y; Tang W; Burlingham WJ; Gulley ML; Kenney SC
J Virol; 2012 Aug; 86(15):7976-87. PubMed ID: 22623780
[TBL] [Abstract][Full Text] [Related]
92. Case Report: Meningoencephalitis With Thrombotic Occlusive Vasculopathy in a Young EBV-Naïve Boy Is Associated With a Novel
Steininger J; Rossmanith R; Geier CB; Leiss-Piller A; Thonhauser L; Weiss S; Hainfellner JA; Freilinger M; Schmidt WM; Eibl MM; Wolf HM
Front Immunol; 2021; 12():747738. PubMed ID: 34987501
[TBL] [Abstract][Full Text] [Related]
93. Epstein-Barr Virus
Magg T; Schober T; Walz C; Ley-Zaporozhan J; Facchetti F; Klein C; Hauck F
Front Immunol; 2018; 9():368. PubMed ID: 29535735
[TBL] [Abstract][Full Text] [Related]
94. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
95. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
[TBL] [Abstract][Full Text] [Related]
96. Epstein Barr Virus Infection Can be a Secondary Event in B-Cell Lymphomas: A Review of 338 Cases and a Novel Finding of Zonal EBER+ Tumor Cells Showing Features of Progression From Underlying EBV-negative Lymphoma.
Miller IJ
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):165-173. PubMed ID: 28800008
[TBL] [Abstract][Full Text] [Related]
97. Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection.
Zhang B; Zong Y; He J; Zhong B; Lin S
Chin Med J (Engl); 2003 Jun; 116(6):913-7. PubMed ID: 12877806
[TBL] [Abstract][Full Text] [Related]
98. Case report: Multiple epstein-barr virus-associated smooth muscle tumours in a child with IL-2-inducible T-cell kinase mutation of undetermined clinical significance.
Wen Q; Ning J; Mao Z; Long X; He X; Chen Z; Di Q; Li Q; Zhuo Y; Zhong G
Front Pediatr; 2023; 11():1189219. PubMed ID: 37465420
[TBL] [Abstract][Full Text] [Related]
99. Mapping the SLP76 interactome in T cells lacking each of the GRB2-family adaptors reveals molecular plasticity of the TCR signaling pathway.
Ruminski K; Celis-Gutierrez J; Jarmuzynski N; Maturin E; Audebert S; Malissen M; Camoin L; Voisinne G; Malissen B; Roncagalli R
Front Immunol; 2023; 14():1139123. PubMed ID: 37006259
[TBL] [Abstract][Full Text] [Related]
100. Immunodeficiency with susceptibility to lymphoma with complex genotype affecting energy metabolism (
Brauer N; Maruta Y; Lisci M; Strege K; Oschlies I; Nakamura H; Böhm S; Lehmberg K; Brandhoff L; Ehl S; Parvaneh N; Klapper W; Fukuda M; Griffiths GM; Hennies HC; Niehues T; Ammann S
Front Immunol; 2023; 14():1151166. PubMed ID: 37388727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
